OOIR: Observatory of International Research

Papers

(The H4-Index of Bioorganic & Medicinal Chemistry Letters is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Editorial Board	108
Pyrazolo-1-carbothioamides as EGR-1–DNA binding disruptors	75
Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor	56
Armeniaspirol analogues disrupt the electrical potential (ΔΨ) of the proton motive force	52
Graphical Abstract TOC	44
Editorial Board	39
Neuropilin 1-targeted near-infrared fluorescence probes for tumor diagnosis	37
Contents continued	34
Synthesis and biological evaluation of novel 1,2,3,4-tetrahydro-β-carboline derivatives as potential antibacterial agents	33
Studies on in vitro modulatory effects to base excision repair enzymes induced by small molecule binding to Deaminated CAG repeat hairpin	30
Design, synthesis and biological evaluation of alginate oligosaccharide derivatives	30
Design and evaluation of anaplastic lymphoma kinase degraders using a covalent fumarate handle	30
Discovery of multitargeting single agents as a novel route to the potential treatment of neurodegenerative diseases	29
SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads	27
Design and synthesis of Tetrahydroindeno[4,5-c]chromen-4(3H)-one derivatives as antiproliferative agents for prostate Cancer cells	27
Phytochemical investigation of Asarum sieboldii var. seoulense and the phenotypic profiles of its constituents against a Parkinson’s Disease olfactory cell line	26
Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia	26
Epigallocatechin and epigallocatechin-3-gallate are not inhibitors of tyrosinase	26
Improved synthesis and anticancer activity of a potent neuronal nitric oxide synthase inhibitor	25
Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents	25
New class of fused [3,2-b][1,2,4]triazolothiazoles for targeting glioma in vitro	24
Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model	24
Synthesis and evaluation of novel oxanthrene scaffold-derived oxazolidinone antibiotics with potent antitubercular activity and low cellular toxicity	24
Green synthesis and anti-biofilm activities of 3,5-disubstituted isoxazoline/isoxazole-linked secondary sulfonamide derivatives on Pseudomonas aeruginosa	24